Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders

The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chen, Wei, Wigginton, Jon Marc, Pandya, Naimish Bharat, Bonvini, Ezio, Moore, Paul A
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Chen, Wei Wigginton, Jon Marc Pandya, Naimish Bharat Bonvini, Ezio Moore, Paul A
description	The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns such molecules that are bispecific antibodies or bispecific diabodies (and especially such diabodies that additionally comprise an Fc Domain). The invention is directed to the use of such molecules, and to the use of pharmaceutical compositions that contain such molecules in the treatment of inflammatory diseases or conditions.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017278329BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017278329BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017278329BB23</originalsourceid><addsrcrecordid>eNqNy7EOgjAUhWEWB6O-wx1cSbQMyGhR4-KmM6n0Fpq0t6S3JPr2gvEBnP6c5DvLjG6Y-qAZTIiQeoSREYKB-lQICa-pZSXzpyVtqQMfHLajQwZLX50iquSR0vyxZJzyXqUQ36Ato-JJKtLzCFFj5HW2MMoxbn5dZdvL-V5fcxxCgzyoFglTc3yI3b4U5aEQlZSi-JN9AOB9QhY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders</title><source>esp@cenet</source><creator>Chen, Wei ; Wigginton, Jon Marc ; Pandya, Naimish Bharat ; Bonvini, Ezio ; Moore, Paul A</creator><creatorcontrib>Chen, Wei ; Wigginton, Jon Marc ; Pandya, Naimish Bharat ; Bonvini, Ezio ; Moore, Paul A</creatorcontrib><description>The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns such molecules that are bispecific antibodies or bispecific diabodies (and especially such diabodies that additionally comprise an Fc Domain). The invention is directed to the use of such molecules, and to the use of pharmaceutical compositions that contain such molecules in the treatment of inflammatory diseases or conditions.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=AU&NR=2017278329B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=AU&NR=2017278329B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wigginton, Jon Marc</creatorcontrib><creatorcontrib>Pandya, Naimish Bharat</creatorcontrib><creatorcontrib>Bonvini, Ezio</creatorcontrib><creatorcontrib>Moore, Paul A</creatorcontrib><title>Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders</title><description>The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns such molecules that are bispecific antibodies or bispecific diabodies (and especially such diabodies that additionally comprise an Fc Domain). The invention is directed to the use of such molecules, and to the use of pharmaceutical compositions that contain such molecules in the treatment of inflammatory diseases or conditions.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EOgjAUhWEWB6O-wx1cSbQMyGhR4-KmM6n0Fpq0t6S3JPr2gvEBnP6c5DvLjG6Y-qAZTIiQeoSREYKB-lQICa-pZSXzpyVtqQMfHLajQwZLX50iquSR0vyxZJzyXqUQ36Ato-JJKtLzCFFj5HW2MMoxbn5dZdvL-V5fcxxCgzyoFglTc3yI3b4U5aEQlZSi-JN9AOB9QhY</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>Chen, Wei</creator><creator>Wigginton, Jon Marc</creator><creator>Pandya, Naimish Bharat</creator><creator>Bonvini, Ezio</creator><creator>Moore, Paul A</creator><scope>EVB</scope></search><sort><creationdate>20240808</creationdate><title>Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders</title><author>Chen, Wei ; Wigginton, Jon Marc ; Pandya, Naimish Bharat ; Bonvini, Ezio ; Moore, Paul A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017278329BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wigginton, Jon Marc</creatorcontrib><creatorcontrib>Pandya, Naimish Bharat</creatorcontrib><creatorcontrib>Bonvini, Ezio</creatorcontrib><creatorcontrib>Moore, Paul A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Chen, Wei</au><au>Wigginton, Jon Marc</au><au>Pandya, Naimish Bharat</au><au>Bonvini, Ezio</au><au>Moore, Paul A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders</title><date>2024-08-08</date><risdate>2024</risdate><abstract>The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns such molecules that are bispecific antibodies or bispecific diabodies (and especially such diabodies that additionally comprise an Fc Domain). The invention is directed to the use of such molecules, and to the use of pharmaceutical compositions that contain such molecules in the treatment of inflammatory diseases or conditions.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_AU2017278329BB2
source	esp@cenet
subjects	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
title	Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A05%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Chen,%20Wei&rft.date=2024-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017278329BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true